Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive examination. Proponents often emphasize the potential for substantial therapeutic gains, principally in diseases where conventional medications have proven inadequate. However, this is to assess the significant financial burden associated with CPI stem cell therapy